172 related articles for article (PubMed ID: 18268491)
21. Cortactin and phosphorylated cortactin tyr
Marioni G; Lionello M; Marchese-Ragona R; Fasanaro E; Valentini E; Zanoletti E; Stritoni P; Ramacciotti G; Guzzardo V; Giacomelli L; Ralli G; Ottaviano G; Blandamura S
Int J Biol Markers; 2018 Jan; 33(1):79-86. PubMed ID: 28885660
[TBL] [Abstract][Full Text] [Related]
22. Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance.
Jarmuz M; Grenman R; Golusinski W; Szyfter K
Cancer Genet Cytogenet; 2005 Jul; 160(1):82-8. PubMed ID: 15949577
[TBL] [Abstract][Full Text] [Related]
23. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
Bellacosa A; Almadori G; Cavallo S; Cadoni G; Galli J; Ferrandina G; Scambia G; Neri G
Clin Cancer Res; 1996 Jan; 2(1):175-80. PubMed ID: 9816104
[TBL] [Abstract][Full Text] [Related]
25. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
26. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
[TBL] [Abstract][Full Text] [Related]
27. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review.
Schuuring E
Gene; 1995 Jun; 159(1):83-96. PubMed ID: 7607576
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes.
Capaccio P; Pruneri G; Carboni N; Pagliari AV; Quatela M; Cesana BM; Pignataro L
Head Neck; 2000 May; 22(3):234-40. PubMed ID: 10748446
[TBL] [Abstract][Full Text] [Related]
29. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
30. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
Mielcarek-Kuchta D; Olofsson J; Golusinski W
Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
Fortin A; Guerry M; Guerry R; Talbot M; Parise O; Schwaab G; Bosq J; Bourhis J; Salvatori P; Janot F; Busson P
Clin Cancer Res; 1997 Sep; 3(9):1609-14. PubMed ID: 9815850
[TBL] [Abstract][Full Text] [Related]
32. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.
Jarmuz-Szymczak M; Pelinska K; Kostrzewska-Poczekaj M; Bembnista E; Giefing M; Brauze D; Szaumkessel M; Marszalek A; Janiszewska J; Kiwerska K; Bartochowska A; Grenman R; Szyfter W; Szyfter K
Mol Biol Rep; 2013 Jul; 40(7):4161-71. PubMed ID: 23652995
[TBL] [Abstract][Full Text] [Related]
35. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
[TBL] [Abstract][Full Text] [Related]
36. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC).
Blessmann M; Al-Dam A; Hanken H; Assaf AT; Riecke B; Klatt J; Simon R; Sauter G; Heiland M; Kluwe L; Gröbe A
J Craniomaxillofac Surg; 2013 Dec; 41(8):845-9. PubMed ID: 23453270
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
39. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
